Send me real-time posts from this site at my email

Company News for Jan 12, 2022

  • Shares of Accolade, Inc. ACCD soared 27.7% after the company reported third-quarter fiscal 2021 revenues of $83.45 million, surpassing the Zacks Consensus Estimate.
  • Pacific Biosciences of California, Inc.’s PACB shares declined 11.3% after the company lowered its fourth-quarter fiscal 2021 sales guidance.
  • Shares of Big Lots, Inc. BIG declined 1.5% after the company said that it has lately witnessed softening of sales trends and traffic this month due to extreme cold weather and surge in Omicron cases.
  • Illumina, Inc.’s ILMN shares jumped 17% after the company raised its 2022 revenue outlook on strong demand for its gene sequencing treatments and four new partnerships with different health care companies.
     

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $2.4 trillion by 2028 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Recommendations from previous editions of this report have produced gains of +205%, +258% and +477%. The stocks in this report could perform even better.

See these 7 breakthrough stocks now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Illumina, Inc. (ILMN): Free Stock Analysis Report
 
Big Lots, Inc. (BIG): Free Stock Analysis Report
 
Pacific Biosciences of California, Inc. (PACB): Free Stock Analysis Report
 
Accolade, Inc. (ACCD): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue